Aussie biotech firm to acquire majority stake in Chinese medical company

Life Science

Chinese investors to buy SciClone Pharmaceuticals, firm valued at $605m

Life Science

Qiming Invests in Boston Startup that Makes Platelets from Stem Cells

Life Science

First Clinical Trial Of Embryonic Stem Cells Is Set To Treat Parkinson’s Disease And Blindness

Life Science

Cancer Screening Tie-up: Hong Kong’s Cirina Merges With GRAIL, an Illumina Spin-Out

Life Science

Taiwan’s OBI Pharma Acquires Cancer Drug from Threshold

Life Science

Biotechnology Incubator Opens Doors in Boston

Life Science

China’s biotech sector to exceed 4% of GDP by 2020: Authority

Life Science, Technology

China’s ‘precision medicine’ initiative gets lift from latest genomics company funding

Life Science